0001362118-21-000003.txt : 20210422
0001362118-21-000003.hdr.sgml : 20210422
20210422180245
ACCESSION NUMBER: 0001362118-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210418
FILED AS OF DATE: 20210422
DATE AS OF CHANGE: 20210422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strawn John R Jr
CENTRAL INDEX KEY: 0001721394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 21845979
MAIL ADDRESS:
STREET 1: C/O IMMUDYNE, INC.
STREET 2: 1460 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-04-18
0
0000948320
LifeMD, Inc.
LFMD
0001721394
Strawn John R Jr
C/O LIFEMD, INC.
800 THIRD AVE, STE 2800
NEW YORK
NY
10022
1
0
0
0
Common Stock, par value $0.01
2021-04-18
4
M
0
200000
1
A
203467
D
Common Stock, par value $0.01
2021-04-18
4
F
0
20060
9.97
D
183407
D
Common Stock, par value $0.01
2021-04-18
4
M
0
100000
2
A
283407
D
Common Stock, par value $0.01
2021-04-18
4
F
0
20060
9.97
D
263347
D
Common Stock, par value $0.01
60000
I
Strawn Pickens LLP
Option
1
2021-04-18
4
M
0
200000
0
D
2011-04-20
2021-04-20
Common Stock, par value $0.01
200000
0
D
Option
2
2021-04-18
4
M
0
100000
0
D
2011-04-20
2021-04-20
Common Stock, par value $0.01
100000
0
D
The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person.
Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement.
Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement.
Mr. Strawn has shared voting and dispositive power and as partner of Strawn Pickens LLP he shares a pecuniary interest. The shares were subject to a 1-for-5 reverse stock split in October, 2020.
The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.
The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.
/s/ John R. Strawn, Jr.
2021-04-22